CRISPR therapy EBT-101 targeted HIV DNA inside living humans for the first time, showing strong safety results but failing to ...

LANSING, Mich. (WLNS) — In the 1980s and 90s, the word AIDS — Acquired Immuno-Deficiency Syndrome — conjured up images of skeletal people dying. It was a constellation of infections that killed people ...

HIV virus is one of the most pressing health concerns facing the modern world. Since the first reported case of HIV/AIDS in 1981, over 25 million people have died. Out of the millions of people ...

Excision BioTherapeutics has so far released positive safety data from the first 3 participants living with HIV-1, with no evidence of vector shedding in sexual organ tissue. A cure for HIV-1 becomes ...

EBT-101 is a potentially curative, one-time CRISPR-based treatment which makes two cuts in integrated retroviral DNA to remove large portions of the HIV genome and prevent HIV from escaping and ...

Credit: Getty Images. A phase 1/2 trial is evaluating the gene therapy in adult patients with HIV-1 who are on stable ART. The Food and Drug Administration (FDA) has granted Fast Track designation to ...